ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
Abstract Angiotensin-converting enzyme 2 (ACE2), a counter regulator of the renin-angiotensin system, provides protection against several chronic diseases. Besides chronic diseases, ACE2 is the host receptor for SARS-CoV or SARS-CoV-2 virus, mediating the first step of virus infection. ACE2 levels a...
Main Authors: | Chia-Wen Wang, Huai-Chia Chuang, Tse-Hua Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Biomedical Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12929-023-00965-9 |
Similar Items
-
Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein
by: Lingbing Zhang, et al.
Published: (2022-06-01) -
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
by: Tümay Capraz, et al.
Published: (2021-12-01) -
ACE2 as a Therapeutic Target for COVID-19; Its Role in Infectious Processes and Regulation by Modulators of the RAAS System
by: Veronique Michaud, et al.
Published: (2020-07-01) -
Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking
by: Sally Badawi, et al.
Published: (2022-09-01) -
Quantifying Renin-Angiotensin-System Alterations in COVID-19
by: Fabrizio Pucci, et al.
Published: (2021-10-01)